Showing results (31-40 of 5,665) with videos related to
Sort By:
Pageof 567
The Oncologist|August 28, 2010
Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trialPaolo Pronzato, Enrico Cortesi, Carin C van der Rijt, et al.The Oncologist|January 8, 2011
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximabMario Scartozzi, Alessandra Mandolesi, Riccardo Giampieri, et al.The Oncologist|May 29, 2010
Review on quality of life issues in patients with primary brain tumorsMartin J B Taphoorn, Eefje M Sizoo, Andrew BottomleyThe Oncologist|December 9, 2010
The biological framework: translational research from bench to clinicYosef YardenThe Oncologist|February 3, 2009
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignanciesMichael J Guarino, Charles J Schneider, Martha A Hosford, et al.The Oncologist|July 22, 2010
Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled studyAntonio Macciò, Clelia Madeddu, Giulia Gramignano, et al.The Oncologist|November 6, 2010
Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastasesMatti Aapro, Fred Saad, Luis CostaThe Oncologist|April 7, 2011
Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigationMartin B Niederle, Bruno NiederleThe Oncologist|March 29, 2011
Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a reviewDorothy Keefe, Joanne Bowen, Rachel Gibson, et al.Pageof 567